• The Magazine
  • Advertising
  • About Us
  • Contact
  • Subscribe
  • Sign in
  • Pharma
  • Medtech
  • Biotech
  • Science
  • Events
  • Careers
  • Jobs
  • Opinion & Debate
  • The Magazine
  • Advertising
  • About Us
  • Contact
Menu
  • Subscribe
  • Sign in

No 04 2016

Malin Otmani

-

December 18, 2016

Share article on X
Share article on Linkedin

Updated: April 11, 2025, 02:17 pm

Published: December 18, 2016

Top stories

Digital health – February 16, 2026

Gosta Lab’s AI Operating System registered as medical device in EUDAMED

It is the first AI operating system in Europe to achieve registration in EUDAMED as a medical device, according to the company.

MedTech Business – February 16, 2026

FDA grants De Novo Classification request from Amferia

Amferia’s antibacterial wound dressing has been granted approval by the US Food and Drug Administration (FDA) through the De Novo Classification Request track, allowing Amferia to enter the US market with a unique Class 2 medical device antibacterial dressing for advanced wound care.

Agreement – February 16, 2026

Ribocure in global licensing agreement

Suzhou Ribo Life Science and its Swedish subsidiary Ribocure Pharmaceuticals have entered into an exclusive worldwide licensing agreement with Madrigal Pharmaceuticals for six pre-clinical small interfering RNA (siRNA) programs for the treatment of metabolic dysfunction-associated steatohepatitis (MASH).

Career choice – February 16, 2026

PhD Interview: “I enjoy bringing structure to complexity”

María Bueno Álvez is a final year PhD student at SciLifeLab and the KTH Royal Institute of Technology, working in the Human Protein Atlas under the supervision of Professor Mathias Uhlén.

Follow NLS news
Follow us on XFollow us on LinkedinFollow us on Bluesky

Related posts

Digital health - February 16, 2026

Gosta Lab’s AI Operating System registered as medical device in EUDAMED

It is the first AI operating system in Europe to achieve registration in EUDAMED as a medical device, according to the company.

MedTech Business - February 16, 2026

FDA grants De Novo Classification request from Amferia

Amferia's antibacterial wound dressing has been granted approval by the US Food and Drug Administration (FDA) through the De Novo Classification Request track, allowing Amferia to enter the US market with a unique Class 2 medical device antibacterial dressing for advanced wound care.

Agreement - February 16, 2026

Ribocure in global licensing agreement

Suzhou Ribo Life Science and its Swedish subsidiary Ribocure Pharmaceuticals have entered into an exclusive worldwide licensing agreement with Madrigal Pharmaceuticals for six pre-clinical small interfering RNA (siRNA) programs for the treatment of metabolic dysfunction-associated steatohepatitis (MASH).

Career choice - February 16, 2026

PhD Interview: “I enjoy bringing structure to complexity”

María Bueno Álvez is a final year PhD student at SciLifeLab and the KTH Royal Institute of Technology, working in the Human Protein Atlas under the supervision of Professor Mathias Uhlén.

Careers article - February 15, 2026

Corporate storytelling – Populate your trademark with reality

The method of storytelling has been an excellent way to spread information, knowledge and experiences for centuries.

Business article - February 12, 2026

New coalition aims to strengthen Europe’s life science investment ecosystem

The European Life Sciences Coalition (ELSC) aims to strengthen Europe’s life sciences and biotechnology VC ecosystem by mobilizing greater levels of private and public investment across the sector.

Acquisition - February 12, 2026

Devyser acquires Cybergene

Devyser Diagnostics has entered into an agreement relating to the acquisition of 100 percent of the shares in Cybergene AB, a Swedish company within the Level Bio group.

Sign up to our Newsletter!

I confirm that I want to subscribe to newsletters from Nordic Life Science and that Nordic Life Science has the right to save my email address. Read our privacy policy here

Read the latest issue!

Sign up for a subscription and read our latest digital issue today.

Sign up
Sign up

The leading life science news channel in the Nordic region.

© NLS Media Group AB – All rights reserved

Digital and print
  • The magazine
  • Subscribe
  • Newsletter
More information
  • About us
  • Contact
  • Advertising
Social media
  • LinkedIn
  • Bluesky
  • X
NLS Media Group AB

St Paulsgatan 13

118 46 Sweden

info@nlsnews.com

+46-8-588 941 51

  • Cookies
  • Data management and privacy policy

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.